Glenzocimab Antibody
Glenzocimab (ACT017) is a humanized anti-GPVI monoclonal antibody Fab fragment. It inhibits collagen-induced platelet aggregation and has been investigated in preclinical stroke models and clinical studies for acute ischemic stroke and cerebral thrombosis.
Product Specifications
Product Name Alternative
Glenzocimab, ACT017, ACT-017, ACT 017
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
4.9 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
48.29 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
